期間限定キャンペーン
【プラスミドDNA精製】もお得!

CAR Expression

VectorBuilderを使って自分のベクターをデザインすることができます。以下によく使われるコンポーネントの解説があります。
CAR-T Domains
名前 詳細 アプリケーションノート レファレンス シークエンス
CD8-leader Leader signal peptide of T-cell surface glycoprotein CD8 alpha chain Directs transport and localization of the protein to the T-cell surface. Cell. 64:891 (1991); WO2014055771A1; US20160185862A1; US10144770B2 View
CD8-hinge Hinge region of T-cell surface glycoprotein CD8 alpha chain Connects scFv and the transmembrane region; enhances tumor recognition efficiency; improves the expansion of CAR-T cells. Cell. 64:891 (1991); J Immunother. 28:203 (2005); BMJ Open. 6: e013904 (2016); J Hematol Oncol. 10: 68 (2017); Oncoimmunology. 7: e1368604 (2018) View
CD28-hinge Hinge region of the T-cell surface glycoprotein CD28 Connects scFv with the transmembrane region providing stability and flexibilty for efficient CAR expression and function; enhances efficiency of tumor recognition; improves expansion of CAR-T cells. J Immunother. 32:689 (2009); Mol Ther. 25:2452 (2017) View
CD8-TM Transmembrane region of T-cell surface glycoprotein CD8 alpha chain Anchors the CAR to the plasma membrane, bridges the extracellular hinge and antigen recognition domains with the intracellular signaling region. Cell. 64:891 (1991); BMJ Open. 6: e013904 (2016); Oncoimmunology. 7: e1368604 (2018); WO2014055771A1; US20100105136A1 View
CD28-TM Transmembrane region of T-cell-surface glycoprotein CD28 Anchors the CAR to the plasma membrane; enhances receptor expression and stability. Hum Gene Ther. 24:259 (2013); Cancer Res. 74:6383 (2014); WO2014055771A1; US10144770B2 View
Costimulatory Domains
名前 詳細 アプリケーションノート レファレンス シークエンス
CD28 CD28 intracellular costimulatory domain Improves overall survival, proliferation and persistence of activated CAR-T cells. Nat Biotechnol. 20:70 (2002); J Immunother. 32:689 (2009); WO2014055771A1 View
4-1BB 4-1BB intracellular costimulatory domain Improves overall survival, proliferation and persistence of activated CAR-T cells; further enhances cytotoxicity and durability when used in combination with CD28. Leukemia. 18:676 (2004); Mol Ther. 17:1453 (2009); EP2904106A2 View
マイベクターをデザインする デザインサポートを依頼する